Objectives With today’s study we wished to explore the impact of treatment having a tumor necrosis factor- -inhibitor (TNFi) on degrees of soluble biomarkers in arthritis rheumatoid (RA) patients also to identify predictors of impaired drug levels and development of anti-TNFi antibodies (anti-TNFi Abs). using C-reactive proteins) and degrees of IL-6 and sTNF-R2 reduced significantly… Continue reading Objectives With today’s study we wished to explore the impact of